Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2016BMC CancerOpen Access

The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome

View Full Paper
Ask AI
Bookmark
Share

Key result

Breast cancer patients with positive epithelial and low stromal periostin expression had the lowest mortality risk, whereas those with high or low expression in both compartments had the worst outcomes.

Why the study?

Does the pattern of stromal and epithelial periostin expression predict mortality in women with breast cancer?

Population

200 women with breast cancer, tumour samples obtained at the time of mastectomy

Design

Cohort

Follow-up

median 18.7 years (range 0.5-29.5 years)

Authors

PNPier Vitale NuzzoNewYork–Presbyterian HospitalARA. RubagottiUniversity of GenoaLZLinda ZinoliMartin University

Discussion

Loading...

Member takes

Implication

PN epithelial/stromal IHC patterns may refine long-term mortality risk stratification in breast cancer; leaves open validation in larger prospective cohorts.

Study Design

Type

Cohort (n=200)

Multicenter

No

Structured PICO

Does the pattern of stromal and epithelial periostin expression predict mortality in women with breast cancer?

P
Population
200 women with histologically confirmed breast cancer, followed for a median of 18.7 years.
E
Exposure
Assessment of epithelial and stromal periostin (PN) expression using immunohistochemistry on tissue microarrays
O
Outcome
All-cause and cancer-specific mortalityhard clinical

The combined pattern of epithelial and stromal periostin expression may serve as an independent prognostic signature for mortality in breast cancer patients.

Limitations

  • Retrospective cohort study design
  • Relatively small patient cohort
  • Patient population may not represent current average population of newly diagnosed breast cancer
  • Therapeutic standards have changed over time
  • Methodological issues related to the scoring method for periostin expression
  • Requires further validation through larger studies

Cite This Study

Nuzzo et al. (2016) conducted a cohort in Breast cancer (n=200). Stromal and epithelial periostin expression vs. Different expression patterns (e.g., low vs high expression) was evaluated on All-cause and breast cancer-specific mortality. Breast cancer patients with positive epithelial and low stromal periostin expression had the lowest mortality risk, whereas those with high or low expression in both compartments had the worst outcomes.

synapsesocial.com/papers/6a9e61ba554b0eaf29acbb3fhttps://doi.org/10.1186/s12885-016-2139-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)2015 · 38 citations
  2. 2Cancer Stem Cell-Related Gene Periostin: A Novel Prognostic Marker for Breast Cancer2012 · 76 citations
  3. 3Role of alternative splicing of periostin in human bladder carcinogenesis2008 · 65 citations
  4. 4A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk1988 · 5,029 citations
  5. 5Gene Expression Profiling of Breast Cancer: A New Tumor Marker2005 · 156 citations